Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 5/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 5/20 | 0.60 |
| ▸ | RELA | Q04206 | 5/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 6/20 | 0.59 |
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | GAA | P10253 | 5/20 | 0.59 |
| ▸ | PKM | P14618 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | GLA | P06280 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 8/20 | 0.50 |
| ▸ | RAB9A | P51151 | 8/20 | 0.50 |
| ▸ | STAT1 | P42224 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 6/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5164826 | 0.83 | APP (0.43) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL12967444 | 0.81 | SMN1; SMN2 (0.62) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL507537 | 0.81 | KDM4E (0.67) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL12596887 | 0.81 | APP (0.68) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL10230259 | 0.81 | KDM4E (0.62) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL12596888 | 0.81 | KDM4E (0.62) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL506665 | 0.81 | KDM4E (0.62) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL12596891 | 0.81 | KDM4E (0.79) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL12967447 | 0.80 | KDM4E (0.61) | KDM4ESMN1; SMN2NFKB1NFKB2RELA | |
| SCHEMBL28759231 | 0.79 | KDM4E (0.59) | KDM4ESMN1; SMN2NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120253040-A1 | OXADIAZOLE DERIVATIVE HAVING ENDOTHELIAL LIPASE INHIBITORY ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2012-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120253040-A1 | OXADIAZOLE DERIVATIVE HAVING ENDOTHELIAL LIPASE INHIBITORY ACTIVITY | LIPG, LPL, CEL | KDM4E 845/4885SMN1; SMN2 4057/4885NFKB1 1897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.